Long-Term Oxygen Therapy in COPD: Factors Affecting and Ways of Improving Patient Compliance

Stamatis Katsenos, Stavros H Constantopoulos, Stamatis Katsenos, Stavros H Constantopoulos

Abstract

Long-term oxygen therapy (LTOT) is the cornerstone mode of treatment in patients with severe chronic obstructive pulmonary disease (COPD) associated with resting hypoxaemia. When appropriately prescribed and correctly used, LTOT has clearly been shown to improve survival in hypoxemic COPD patients. Adherence to LTOT ranges from 45% to 70% and utilization for more than 15 hours per day is widely accepted as efficacious. Although several studies have addressed the level of patients' adherence to LTOT, few have suggested or evaluated interventions that conduce to compliance enhancement. The lack of sufficient data regarding COPD patients following oxygen prescription is an enormous void that must be duly confronted to augment clinical effectiveness and cost containment for the long term use. The present review article highlights factors influencing the compliance of patients using LTOT and emphasizes novel strategies and interventions that may prove to be of significant benefit given the remarkably little current research appraising this issue. Therefore, additional research should be promptly performed to verify the efficacy of newly designed approaches in improving the outcomes of patients receiving LTOT.

Figures

Figure 1
Figure 1
Long-term oxygen therapy: a research agenda for compliance.

References

    1. Kvale PA, Conway WA, Coates EO. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. A clinical trial. Annals of Internal Medicine. 1980;93(3):391–398.
    1. Stuart-Harris C, Bishop JM, Clark TJH. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. The Lancet. 1981;1(8222):681–686.
    1. Petty TL, Bliss PL. Ambulatory oxygen therapy, exercise, and survival with advanced chronic obstructive pulmonary disease (the nocturnal oxygen therapy trial revisited) Respiratory Care. 2000;45(2):204–213.
    1. Crockett AJ, Cranston JM, Moss JR, Alpers JH. A review of long-term oxygen therapy for chronic obstructive pulmonary disease. Respiratory Medicine. 2001;95(6):437–443.
    1. Eaton T, Lewis C, Young P, Kennedy Y, Garrett JE, Kolbe J. Long-term oxygen therapy improves health-related quality of life. Respiratory Medicine. 2004;98(4):285–293.
    1. Mitrouska I, Tzanakis N, Siafakas NM. Oxygen therapy in chronic obstructive pulmonary disease. European Respiratory Monograph. 2006;11(38):302–312.
    1. Wedzicha JA. Effects of long-term oxygen therapy on neuropsychiatric function and quality of life. Respiratory Care. 2000;45(2):223–228.
    1. Kim V, Benditt JO, Wise RA, Sharafkhaneh A. Oxygen therapy in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society. 2008;5(4):513–518.
    1. Ringbaek JJ, Viskum K, Lange P. Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease? European Respiratory Journal. 2002;20(1):38–42.
    1. Morrison DA, Stovall JR. Increased exercise capacity in hypoxemic patients after long-term oxygen therapy. Chest. 1992;102(2):542–550.
    1. Zieliński J, Tobiasz M, Hawryłkiewicz I, Śliwiński P, Pałasiewicz G. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. Chest. 1998;113(1):65–70.
    1. Weitzenblum E, Sautegeau A, Ehrhart M. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. American Review of Respiratory Disease. 1985;131(4):493–498.
    1. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. European Respiratory Journal. 2004;23(6):932–946.
    1. Cullen DL. Long term oxygen therapy adherence and COPD: what we don’t know. Chronic Respiratory Disease. 2006;3(4):217–222.
    1. Dunne PJ. The demographics and economics of long-term oxygen therapy. Respiratory Care. 2000;45(2):223–230.
    1. O’Donohue WJ, Plummer AL. Magnitude of usage and cost of home oxygen therapy in the United States. Chest. 1995;107(2):301–302.
    1. Rous MRG. Long-term oxygen therapy: are we prescribing appropriately? International Journal of COPD. 2008;3(2):231–237.
    1. Corrado A, Renda T, Bertini S. Long-term oxygen therapy in COPD: evidences and open questions of current indications. Monaldi Archives for Chest Disease. 2010;73(1):34–43.
    1. Pépin JL, Barjhoux CE, Deschaux C, Brambilla C. Long-term oxygen therapy at home: compliance with medical prescription and effective use of therapy. Chest. 1996;109(5):1144–1150.
    1. Howard P, Waterhouse JC, Billings CG. Compliance with long-term oxygen therapy by concentrator. European Respiratory Journal. 1992;5(1):128–129.
    1. Walshaw MJ, Lim R, Evans CC, Hind CRK. Factors influencing the compliance of patients using oxygen concentrators for long-term home oxygen therapy. Respiratory Medicine. 1990;84(4):331–333.
    1. Granados A, Escarrabill J, Borràs JM, Rodríguez-Roisín R. The importance of process variables analysis in the assessment of long-term oxygen therapy by concentrator. Respiratory Medicine. 1997;91(2):89–93.
    1. Katsenos S, Froudarakis ME, Charisis A, Vassiliou MP, Constantopoulos SH. Long-term oxygen therapy in Ioannina. Respiration. 2004;71(6):619–624.
    1. Avdeev SN, Aisanov ZR, Chuchalin AG. Compliance as a critical issue in long-term oxygen therapy. Monaldi Archives for Chest Disease. 1999;54(1):61–66.
    1. Evans TW, Waterhouse J, Howard P. Clinical experience with the oxygen concentrator. British Medical Journal. 1983;287(6390):459–461.
    1. Walshaw MJ, Lim R, Evans CC, Hind CRK. Prescription of oxygen concentrators for long term oxygen treatment: reassessment in one district. British Medical Journal. 1987;297(6655):1030–1032.
    1. Vergeret J, Brambilla C, Mounier L. Portable oxygen therapy: use and benefit in hypoxaemic COPD patients on long-term oxygen therapy. European Respiratory Journal. 1989;2(1):20–25.
    1. Ringbæk T, Lange P, Viskum K. Compliance with LTOT and consumption of mobile oxygen. Respiratory Medicine. 1999;93(5):333–337.
    1. Restrick LJ, Paul EA, Braid GM, Cullinan P, Moore-Gillon J, Wedzicha JA. Assessment and follow up of patients prescribed long term oxygen treatment. Thorax. 1993;48(7):708–713.
    1. Atiş S, Tutluoğlu B, Buğdayci R. Characteristics and compliance of patients receiving long-term oxygen therapy (LTOT) in Turkey. Monaldi Archives for Chest Disease. 2001;56(2):105–109.
    1. Lacasse Y, Lecours R, Pelletier C, Bégin R, Maltais F. Randomised trial of ambulatory oxygen in oxygen-dependent COPD. European Respiratory Journal. 2005;25(6):1032–1038.
    1. Nasiłowski J, Przybyłowski T, Klimiuk J, et al. The effects of frequent nurse visits on patient’s compliance with long-term oxygen therapy (LTOT). A 14-month follow-up. Pneumonology Allergology Polish. 2009;77(4):363–370.
    1. Garcia-Aymerich J, Barreiro E, Farrero E, Marrades RM, Morera J, Antó JM. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study) European Respiratory Journal. 2000;16(6):1037–1042.
    1. Cornford CS. Lay beliefs of patients using domiciliary oxygen: a qualitative study from general practice. British Journal of General Practice. 2000;50(459):791–793.
    1. Earnest MA. Explaining adherence to supplemental oxygen therapy: the patient’s perspective. Journal of General Internal Medicine. 2002;17(10):749–755.
    1. Kampelmacher MJ, Van Kesteren RG, Alsbach GPJ, et al. Characteristics and complaints of patients prescribed long-term oxygen therapy in the Netherlands. Respiratory Medicine. 1998;92(1):70–75.
    1. Oliver SM. Living with failing lungs: the doctor-patient relationship. Family Practice. 2001;18(4):430–439.
    1. Jones P. Health status, quality of life and compliance. European Respiratory Review. 1998;8(56):243–246.
    1. Ringbaek TJ, Lange P. The impact of the Danish Oxygen Register on adherence to guidelines for long-term oxygen therapy in COPD patients. Respiratory Medicine. 2006;100(2):218–225.
    1. Neri M, Melani AS, Miorelli AM, et al. Long-term oxygen therapy in chronic respiratory failure: a Multicenter Italian study on Oxygen Therapy Adherence (MISOTA) Respiratory Medicine. 2006;100(5):795–806.
    1. Marinker M. The current status of compliance. European Respiratory Review. 1998;8(56):235–238.
    1. Lin SKV, Bogen DK, Kuna ST. Validation of a novel device to objectively measure adherence to long-term oxygen therapy. International Journal of COPD. 2008;3(3):435–442.
    1. Rizzi M, Grassi M, Pecis M, et al. A specific home care program improves the survival of patients with chronic obstructive pulmonary disease receiving long term oxygen therapy. Archives of Physical Medicine and Rehabilitation. 2009;90(3):395–401.
    1. Mason RH, Suntharalingam J. Long-term oxygen therapy (LTOT)—Is it always appropriately prescribed? Clinical Medicine. 2009;9(6):p. 634.
    1. Zhu Z, Barnette RK, Fussell KM, Michael Rodriguez R, Canonico A, Light RW. Continuous oxygen monitoring—A better way to prescribe long-term oxygen therapy. Respiratory Medicine. 2005;99(11):1386–1392.
    1. Cullen DL, Stiffler D. Long-term oxygen therapy: review from the patients' perspective. Chronic Respiratory Disease. 2009;6(3):141–147.
    1. Peckham DG, Mcgibbon K, Tonkinson J, Plimbley G, Pantin C. Improvement in patient compliance with long-term oxygen therapy following formal assessment with training. Respiratory Medicine. 1998;92(10):1203–1206.
    1. Ring L, Danielson E. Patients’ experiences of long-term oxygen therapy. Journal of Advanced Nursing. 1997;26(2):337–344.
    1. Katsenos S, Charisis A, Daskalopoulos G, Constantopoulos SH, Vassiliou MP. Long-term oxygen therapy in chronic obstructive pulmonary disease: the use of concentrators and liquid oxygen systems in north-western Greece. Respiration. 2006;73(6):777–782.
    1. Dunne PJ, McInturff SL. Respiratory home care: the essentials. Philadelphia, Pa, USA: FA. Davis; 1998.
    1. Bliss PL, McCoy RW, Adams AB. Characteristics of demand oxygen delivery systems: maximum output and setting recommendations. Respiratory Care. 2004;49(2):160–165.
    1. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006;61(9):772–778.
    1. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131(5 supplement):4S–42S.
    1. Tiep B, Carter R. Oxygen conserving devices and methodologies. Chronic Respiratory Disease. 2008;5(2):109–114.
    1. Dunne PJ. The clinical impact of new long-term oxygen therapy technology. Respiratory Care. 2009;54(8):1100–1111.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner